Glenmark gets USFDA nod for cholesterol drug

Glenmark Pharmaceuticals has received final approval from the U.S. health regulator for Colesevelam Hydrochloride for oral suspension, used to lower cholesterol levels in the blood. The approval has been granted by the USFDA in the strengths of 1.875 grams/packet and 3.75 grams/packet, the firm said in a BSE filing. The approved product is a generic version of Daiichi Sankyo Inc’s Welchol.PTI

Source: Read Full Article